| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
9 companies
Armistice Capital, LLC serves as a 10% Owner at HIND and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 337 buys and 114 sells. Those positions are worth an estimated $10.1M at current prices.
Historically, Armistice Capital, LLC's trades have earned a middling insider score of 56/100 across 42 rated trades. Over a 12-month horizon, 23.8% of those trades were profitable, with an average 12-month return of -33.4%.
The biggest single holding is ACHV (~$3.7M) as 10% Owner. The recent filings there lean toward selling, a net 299,332 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2019 | VXRT Vaxart, Inc. | 10% Owner | Buy | 7,333,333 | $0.29 | $2,143,078.47 | +44.0% | |
| Sep 23, 2019 | TRAW Traws Pharma, Inc. | 10% Owner | Sell | 10,249 | $1.27 | $13,016.23 | -1.2% | |
| Sep 6, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 2,200,000 | $3.05 | $6,706,000.00 | +11.9% | |
| Aug 30, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 41,764 | $3.22 | $134,554.26 | +0.2% | |
| Aug 19, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 12,184 | $3.46 | $42,189.23 | - | |
| Aug 14, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 100,000 | $3.33 | $332,581.94 | +33.3% | |
| Jun 11, 2019 | ACHV Achieve Life Sciences, Inc. | 10% Owner | Sell | 267,575 | $3.28 | $876,941.16 | -24.1% | |
| Jun 11, 2019 | ACHV Achieve Life Sciences, Inc. | 10% Owner | Buy | 12,813 | $3.80 | $48,689.40 | +1.3% | |
| Jun 11, 2019 | ACHV Achieve Life Sciences, Inc. | 10% Owner | Sell | 47,182 | $2.86 | $134,820.70 | -5.6% | |
| Jun 7, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 10,000 | $4.88 | $48,750.00 | +3.4% |